BIT225-009 phase II study demonstrates significant immunological benefits in HIV-infected patients Oct. 1, 2018
IAVI enrolling healthy volunteers for first-in-human study of eOD-GT8 60mer vaccine, adjuvanted Sep. 4, 2018
Dissemination of data from four phase I studies GSK-2838232, a second-generation drug for HIV Aug. 29, 2018
Cabotegravir/rilpivirine regimen shows noninferiority to three-drug regimen for HIV infection Aug. 16, 2018
RSS